|
Section 82.0
|
What is the purpose of this part? |
|
Section 82.1
|
What are the basics of dose reconstruction? |
|
Section 82.2
|
What Are the Requirements for Dose Reconstruction Under EEOICPA? |
|
Section 82.3
|
How Will DOL Use the Results of the NIOSH Dose Reconstructions? |
|
Section 82.4
|
Definition of terms used in this part |
|
Section 82.5
|
Overview of the dose reconstruction process |
|
Section 82.10
|
For which claims under EEOICPA will NIOSH conduct a dose reconstruction? |
|
Section 82.11
|
Will it be possible to conduct dose reconstructions for all claims? |
|
Section 82.12
|
What sources of information may be used for dose reconstructions? |
|
Section 82.13
|
What types of information could be used in dose reconstructions? |
|
Section 82.14
|
How will NIOSH evaluate the completeness and adequacy of individual monitoring data? |
|
Section 82.15
|
How will NIOSH add to monitoring data to remedy limitations of individual monitoring and missed dose? |
|
Section 82.16
|
What types of information could be used to supplement or substitute for individual monitoring data? |
|
Section 82.17
|
How will NIOSH calculate internal dose to the primary cancer site(s)? |
|
Section 82.18
|
How will NIOSH address uncertainty about dose levels? |
|
Section 82.19
|
When will NIOSH report dose reconstruction results, and to whom? |
|
Section 82.25
|
How will NIOSH report dose reconstruction results? |
|
Section 82.26
|
How can claimants obtain reviews of their NIOSH dose reconstruction results by NIOSH? |
|
Section 82.27
|
Who can review NIOSH dose reconstruction files on individual claimants? |
|
Section 82.28
|
How will NIOSH inform the public of any plans to change scientific elements underlying the dose reconstruction process to |
|
Section 82.30
|
How can the public recommend changes to scientific elements underlying the dose reconstruction process? |
|
Section 82.31
|
How will NIOSH make changes in scientific elements underlying the dose reconstruction process, based on scientific |
|
Section 82.32
|
How will NIOSH inform the public of changes to the scientific elements underlying the dose reconstruction process? |
|
Section 82.33
|
Background information on the procedures in this part |